| Mar 28 2025 |
Nebraska Considers Sales Tax on Candy and Soft Drinks |
Keller and Heckman LLP |
| Mar 28 2025 |
FDA Announces a “Chemical Contaminants Transparency Tool” to Evaluate Potential Health Risks of Contaminants in Human Foods. |
Keller and Heckman LLP |
| Mar 28 2025 |
Illinois Moving Forward with BVO Ban |
Keller and Heckman LLP |
| Mar 27 2025 |
Behavioral Health Law Ledger | March 2025 |
Greenberg Traurig, LLP |
| Mar 27 2025 |
EPA Extends 2024 RFS Compliance Reporting Deadline |
Bergeson & Campbell, P.C. |
| Mar 27 2025 |
CLP Changes And What They Mean For Commercial Operations — A Conversation with Karin Baron and Lioba Oerter [Podcast] |
Bergeson & Campbell, P.C. |
| Mar 27 2025 |
China Releases New Rules Regarding the Use of Facial Recognition Technology |
Hunton Andrews Kurth |
| Mar 27 2025 |
What’s the (Re)issue? Patent Term Extensions for Reissue Patents |
McDermott Will & Emery |
| Mar 27 2025 |
China Releases Draft Implementation Measures for the Protection of Drug Trial Data Including Data Exclusivity for Foreign-Originated Drugs |
Schwegman, Lundberg & Woessner, P.A. |
| Mar 26 2025 |
Ghost Guns and the Bankruptcy Code: Neither Provides Ammunition for Dismissing Actions - SCOTUS Today |
Epstein Becker & Green, P.C. |
| Mar 26 2025 |
This Week in 340B: March 18 – 24, 2025 |
McDermott Will & Emery |
| Mar 25 2025 |
DEA Buprenorphine Rule Delayed to December 31, 2025 |
Foley & Lardner LLP |
| Mar 25 2025 |
Telehealth Cliff Averted, for Now (But September is Six Months Away) |
Epstein Becker & Green, P.C. |
| Mar 25 2025 |
The End of the Self-Affirmed GRAS Pathway? |
Epstein Becker & Green, P.C. |
| Mar 24 2025 |
Ex officio interventions by the Anti-Corruption and Good Government Ministry in public tenders in México |
OLIVARES |
| Mar 24 2025 |
DEA Telemedicine Rules Further Delayed Until (Nearly) 2026 |
Epstein Becker & Green, P.C. |
| Mar 24 2025 |
The Ketamine Administration Market: A Legal Guide for Healthcare Entities |
MDRX Law - Sauchik & Giyaur, P.C. |
| Mar 24 2025 |
Federal Circuit Decision Could Encourage More Reissue Patents |
Foley & Lardner LLP |
| Mar 24 2025 |
West Virginia Set to Ban Certain Food Additives and Colors |
Keller and Heckman LLP |
| Mar 24 2025 |
What Vice Chancellor Strine Got Wrong In Massey Energy Co. |
Allen Matkins Leck Gamble Mallory & Natsis LLP |
| Mar 24 2025 |
FDA Plans to Extend Compliance Date for Food Traceability Rule |
Keller and Heckman LLP |
| Mar 21 2025 |
HHS-OIG Highlights Anti-Fraud Safeguards of Drug Manufacturer’s Free Drug Program for Patients in Financial Need |
Barnes & Thornburg LLP |
| Mar 21 2025 |
Federal Circuit Confirms Calculation of PTE for Reissue Patents Under Regulatory Review |
Barnes & Thornburg LLP |
| Mar 21 2025 |
McDermott+ Check-Up: March 21, 2025 |
McDermott Will & Emery |
| Mar 21 2025 |
FDA’s Semaglutide Shortage Resolution: Legal Implications and Risks for Compounding Pharmacies |
Sheppard, Mullin, Richter & Hampton LLP |
| Mar 21 2025 |
President Trump Revokes 2022 EO on Advancing Biotechnology and Biomanufacturing |
Bergeson & Campbell, P.C. |
| Mar 20 2025 |
Maine Considers Bill to Establish Maximum Levels of PFAS in Farm Products |
Keller and Heckman LLP |
| Mar 20 2025 |
FDA Completes Pre-Market Consultation for Food Made With Cultured Pork Fat Cells |
Keller and Heckman LLP |
| Mar 20 2025 |
RFK Jr. Pushes to Ban Synthetic Dyes in Food |
Keller and Heckman LLP |
| Mar 19 2025 |
GT Legal Food Talk Episode 27: From Slam Dunks and Big Tech to Launching New Brands: Alan and Maxine Henderson’s Journey into Food & Beverage Entrepreneurship [Podcast] |
Greenberg Traurig, LLP |
| Mar 19 2025 |
California Delays Extended Producer Responsibility Regulations for Plastic and Packaging: Three Takeaways |
ArentFox Schiff LLP |
| Mar 19 2025 |
What to Take Away from CMMI’s Early Termination of Four Demonstration Models |
Mintz |
| Mar 19 2025 |
Circular Action Alliance Underscores Consequences of Non-Compliance with Upcoming Oregon Packaging EPR Compliance Deadline |
Beveridge & Diamond PC |
| Mar 19 2025 |
Joint Effort: Why a New Crop of House Members, a New Speaker, and Continued Bipartisan Support Could Finally Light the Way for Medical Marijuana in N.C. |
Bradley Arant Boult Cummings LLP |
| Mar 19 2025 |
This Week in 340B: March 11 – 17, 2025 |
McDermott Will & Emery |
